XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net sales $ 668.3 $ 426.4 $ 1,347.3 $ 833.2
Cost of products sold 539.8 326.8 1,109.8 641.0
Gross profit 128.5 99.6 237.5 192.2
Selling expense 23.6 15.0 47.5 29.3
Research and development expense 7.0 5.4 16.1 10.6
General expense 63.8 49.0 129.7 98.3
Total nonmanufacturing expenses 94.4 69.4 193.3 138.2
Restructuring and impairment expense 0.5 2.4 1.3 15.6
Operating profit 33.6 27.8 42.9 38.4
Interest expense 28.2 20.4 54.7 34.9
Other income (expense), net (3.4) 7.3 3.6 12.8
Income (loss) before income taxes and income from equity affiliates 2.0 14.7 (8.2) 16.3
Income tax expense 6.6 4.6 4.2 6.7
Income from equity affiliates, net of income taxes 0.1 1.7 0.2 3.8
Net income (loss) (4.5) 11.8 (12.2) 13.4
Dividends to participating securities (0.1) (0.3) (0.2) (0.5)
Net income (loss) attributable to Common Stockholders, basic (4.6) 11.5 (12.4) 12.9
Net income (loss) attributable to Common Stockholders, diluted $ (4.6) $ 11.5 $ (12.4) $ 12.9
Net income (loss) per share:        
Basic (in dollars per share) $ (0.08) $ 0.36 $ (0.23) $ 0.41
Diluted (in dollars per share) $ (0.08) $ 0.36 $ (0.23) $ 0.41
Weighted average shares outstanding:        
Basic (in shares) 54,656,400 31,260,100 54,570,100 31,209,300
Diluted (in shares) 54,656,400 31,409,800 54,570,100 31,412,000